1. Home
  2. RDHL vs CETX Comparison

RDHL vs CETX Comparison

Compare RDHL & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • CETX
  • Stock Information
  • Founded
  • RDHL 2009
  • CETX 1998
  • Country
  • RDHL Israel
  • CETX United States
  • Employees
  • RDHL N/A
  • CETX N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • CETX EDP Services
  • Sector
  • RDHL Health Care
  • CETX Technology
  • Exchange
  • RDHL Nasdaq
  • CETX Nasdaq
  • Market Cap
  • RDHL 3.9M
  • CETX 4.1M
  • IPO Year
  • RDHL N/A
  • CETX 1998
  • Fundamental
  • Price
  • RDHL $1.51
  • CETX $0.78
  • Analyst Decision
  • RDHL
  • CETX
  • Analyst Count
  • RDHL 0
  • CETX 0
  • Target Price
  • RDHL N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • RDHL 88.5K
  • CETX 1.1M
  • Earning Date
  • RDHL 09-05-2025
  • CETX 08-14-2025
  • Dividend Yield
  • RDHL N/A
  • CETX N/A
  • EPS Growth
  • RDHL N/A
  • CETX N/A
  • EPS
  • RDHL N/A
  • CETX N/A
  • Revenue
  • RDHL $9,550,000.00
  • CETX $76,095,551.00
  • Revenue This Year
  • RDHL $381.91
  • CETX $19.77
  • Revenue Next Year
  • RDHL N/A
  • CETX $15.00
  • P/E Ratio
  • RDHL N/A
  • CETX N/A
  • Revenue Growth
  • RDHL 157.62
  • CETX 16.50
  • 52 Week Low
  • RDHL $1.06
  • CETX $0.76
  • 52 Week High
  • RDHL $11.70
  • CETX $381.57
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 54.23
  • CETX 23.02
  • Support Level
  • RDHL $1.22
  • CETX $0.76
  • Resistance Level
  • RDHL $1.60
  • CETX $0.92
  • Average True Range (ATR)
  • RDHL 0.08
  • CETX 0.08
  • MACD
  • RDHL 0.04
  • CETX -0.03
  • Stochastic Oscillator
  • RDHL 76.32
  • CETX 3.43

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: